Figure 3

Quantitative analyses of GFB permeabilities in progression of hypertensive nephropathy on-a-chip.
(A) Quantification of barrier permeability to FITC-inulin is shown. (B) Quantification of barrier permeability to FITC-BSA is shown. (C) Quantification of barrier permeability to FITC-IgG is shown. Data are the mean ± SD from three separate experiments. *P < 0.05, **P < 0.01 vs. static group; #P < 0.05, ##P < 0.01 vs. 5 μL/min group.